Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
Atsuko Katsuyama,1 Sentaro Kusuhara,1 Ryuto Nishisho,1 Wataru Matsumiya,1 Atsushi Azumi,2 Makoto Nakamura1 1Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe 650-0017, Japan; 2Department of Ophthalmology, Kobe Kaisei Hospital, Nada-ku, Kobe...
Main Authors: | Katsuyama A, Kusuhara S, Nishisho R, Matsumiya W, Azumi A, Nakamura M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-efficacy-and-safety-of-infliximab-and-cyclosporine-combinati-peer-reviewed-article-OPTH |
Similar Items
-
Severe panuveitis in neuro-Behçet’s disease in Malaysia: a case series
by: Othman K, et al.
Published: (2017-02-01) -
Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
by: Abd El Latif E, et al.
Published: (2020-11-01) -
Early versus late initiation of infliximab for refractory uveitis in a cohort of Egyptian BD patients
by: Mariam R Fadel, et al.
Published: (2024-08-01) -
Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study
by: Masaru Takeuchi, et al.
Published: (2023-01-01) -
Twenty Years of Quiescence after Nonstop Remicade® (Infliximab) Infusions in a Child with Ocular Behçet Disease Presenting as Hypopyon-Anterior Uveitis Refractory to Immunosuppressants
by: Cem Evereklioglu
Published: (2023-02-01)